Showing results (961-970 of 8,009) with videos related to
Sort By:
Pageof 801
Current Medicinal Chemistry|September 3, 2013
1, 25(OH)₂D₃ inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytesJian Guo, Zhenhua Ma, Qingyong Ma, et al.Current Medicinal Chemistry|September 3, 2013
Therapeutic perspectives for cN-II in cancerLars Petter Jordheim, Laurent ChaloinCurrent Medicinal Chemistry|September 3, 2013
Is the expression of deoxynucleoside kinases and 5'-nucleotidases in animal tissues related to the biological effects of nucleoside analogs?Staffan ErikssonCurrent Medicinal Chemistry|September 3, 2013
Molecular targeted therapy in enteropancreatic neuroendocrine tumors: from biology to clinical practiceN Fazio, A Scarpa, M FalconiCurrent Medicinal Chemistry|September 3, 2013
Targeted strategies in the treatment of primary gastric lymphomas: from rituximab to recent insights into potential new drugsFrancesca Merchionne, Pasquale Iacopino, Carla Minoia, et al.Current Medicinal Chemistry|September 3, 2013
Targeted therapies in hepatocellular carcinomaF Bronte, G Bronte, S Cusenza, et al.Current Medicinal Chemistry|September 3, 2013
Cellular and molecular background underlying the diversity in therapeutic responses between primary tumours and metastasesSimona Romano, Anna D'Angelillo, Alfredo Romano, et al.Current Medicinal Chemistry|September 3, 2013
Peptide-based radiopharmaceuticals for targeted tumor therapyC Dong, Z Liu, F WangCurrent Medicinal Chemistry|September 3, 2013
PET radiotracers for molecular imaging of serotonin 5-HT1A receptorsT Billard, D Le Bars, L ZimmerCurrent Medicinal Chemistry|July 10, 2013
Targeting proteasomal pathways by dietary curcumin for cancer prevention and treatmentNoor Hasima, Bharat B AggarwalPageof 801